Stem Cell Clinical Trials

Despite decades of research, stem cell therapies have yet to be licensed for ophthalmic use. Where does the field currently stand? We present a graphical representation of all currently ongoing clinical trials in this therapeutic area.

By Mark Hillen and Irv Arons

Stem cells are unspecialized cells that can, given the appropriate stimulation, give rise to differentiated cells of various kinds. Therapies based on stem cell treatments are considered to have tremendous potential in medicine. Ocular diseases are at the forefront of stem cell medicine, in part because the eye is a relatively simple, accessible and easily-monitored organ and also because stem cells in the eye are protected from potentially devastating immune attack by the organ’s immune privilege status.